Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ChrysosCHRCF 35 EBITDA Margin % is 28.56% as of Jun. 2026, which is 9% above its 10-year median of 26.23. GuruFocus rates CHRCF with a GF Score™ of 35/100 and a GF Value™ of $5.45 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 2,825 Software companies, Chrysos ranks better than 89.56% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Chrysos's EBITDA for the
six
months ended in Jun. 2026 was $8.99 Mil. Chrysos's Revenue for the
six
months ended in Jun. 2026 was $31.48 Mil. Therefore, Chrysos's EBITDA margin for the quarter that ended in Jun. 2026 was 28.56%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Chrysos EBITDA Margin % Related Terms
Chrysos EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Chrysos's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHRCF vs QH, SHOP, UBER: EBITDA Margin % Comparison
For the Software - Application subindustry, Chrysos's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chrysos EBITDA Margin % vs Software Industry
For the Software industry and Technology sector, Chrysos's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Chrysos's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chrysos (CHRCF) has a EBITDA Margin % of 28.56% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Chrysos and its competitors. This is near median its historical median of 26.23. Over the past decade, Chrysos' EBITDA Margin % has ranged from 18.98 to 78.11. According to the industry distribution chart, Chrysos ranks #295 out of 2825 companies in the Software industry, placing it in the top 10.4%.
Is Chrysos' EBITDA Margin % too high?
Chrysos' current EBITDA Margin % of 28.56% is near median its 10-year median of 26.23. Over the past 10 years, this metric has ranged from a low of 18.98 to a high of 78.11. The Software industry median EBITDA Margin % is 8.20. Chrysos' value of 28.56% is 248.3% above this industry median. Based on the distribution chart, Chrysos ranks #295 out of 2825 companies in the Software industry, which is in the top quartile — a strong position relative to peers. Overall, Chrysos has a GF Score™ of 35/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chrysos' EBITDA Margin % compare to QH and SHOP?
According to the Software industry distribution chart, Chrysos ranks #295 out of 2825 companies for EBITDA Margin %. This places Chrysos in the top 10% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 8.20. Chrysos' value of 28.56% is 248.3% above this benchmark. Historically, Chrysos' own EBITDA Margin % has ranged from 18.98 to 78.11 over the past decade. While the company's 10-year median is 26.23 vs. the industry median of 8.20, Chrysos has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Software company?
The median EBITDA Margin % among Software companies is 8.20, based on 2,825 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chrysos's current EBITDA Margin % of 28.56% is 248.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Chrysos and its competitors. For the Software industry, the median EBITDA Margin % is 8.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chrysos's current EBITDA Margin % is 28.56%, which is near median its own 10-year median of 26.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chrysos stock overvalued right now?
Based on GuruFocus' analysis, Chrysos (CHRCF) is currently considered Modestly Undervalued. The stock's GF Value™ is $5.45, compared to a current price of $4.15 — trading 23.9% below its estimated fair value. The current EBITDA Margin % is 28.56%, which is near median its 10-year median of 26.23 and 248.3% above the Software industry median of 8.20. Chrysos' overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Chrysos (CHRCF), the current EBITDA Margin % is 28.56% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chrysos (CHRCF) Overvalued in 2026?
Based on GuruFocus' analysis, Chrysos stock appears to be undervalued.
The current stock price of $4.15 is trading 23.9% below its estimated GF Value™ of $5.45.
GuruFocus considers Chrysos to be Modestly Undervalued.
Key valuation signals for CHRCF:
EBITDA Margin %: 28.56% (near median its 10-year median of 26.23)
GF Value™: $5.45 vs. price of $4.15 (23.9% below fair value)
Industry Position: 248.3% above the Software median (#295 of 2825)
No single metric tells the full story. See the CHRCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chrysos Corp Ltd is an Australian-based provider of novel assay services to the international mining industry through its proprietary PhotonAssay technology. The company's flagship product, PhotonAssay, delivers accurate and environmentally friendly analysis of gold, silver, and complementary elements. The Group has three reportable segments, namely, EMEA, APAC, and the Americas, where the majority of revenue is generated from Australia. The Group generates revenue mainly from the deployment of PhotonAssay units with its customers.
35GF Score
Get the complete analysis for CHRCF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHRCF has been successfully added to your 
